Literature DB >> 30367261

Abnormal activation of the Akt signaling pathway in adenoid cystic carcinoma.

Karla Flaviana Carneiro Castelo Branco1, Andre Luis Ribeiro Ribeiro2,3, Raíssa Pinheiro de Mendonça1, João de Jesus Viana Pinheiro1, Maria Sueli da Silva Kataoka1, Maria Vanda Catão Arnaud4, Sérgio de Melo Alves Junior1.   

Abstract

PURPOSE: Adenoid cystic carcinoma (ACC) is an intriguing lesion because it shows a slow growth in the beginning, but a late poor prognosis due to perineural invasion, metastasis and recurrence. This study aimed to investigate whether Akt signaling would be deregulated in adenoid cystic carcinoma and its consequence in the expression of associated proteins.
METHODS: The expression of the Akt, p-Akt, NFκB, β-catenin, cyclin D1 and COX-2 was assessed by immunohistochemistry in 10 cases of ACC, 17 cases of pleomorphic adenoma (PA), and 7 cases of normal salivary gland (NSG).
RESULTS: p-Akt was overexpressed in ACC when compared to NSG. NFκB, β-catenin, and COX-2 were overexpressed in ACC and PA when compared to NSG. Most proteins were slightly higher expressed in ACC than in PA, but they never reached significance. p-Akt expression positively correlated with NFκB, β-catenin, cyclin D1 and COX-2 in ACC and PA, while this correlation trended to be negative in for these proteins (except for NFκB) in NSG using Person's correlation analysis, but without reaching significance.
CONCLUSIONS: Our results indicate an abnormal activation of Akt signaling pathway, which can be an important regulator of tumor biology in ACC. Activated Akt correlated with the expression of NFκB, β-catenin and COX-2, which can potentially influence cell survival in ACC.

Entities:  

Keywords:  Adenoid cystic carcinoma; Akt; NFκB; Pleomorphic adenoma; Salivary gland tumors

Mesh:

Substances:

Year:  2018        PMID: 30367261     DOI: 10.1007/s00405-018-5182-2

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  44 in total

1.  Akt activation by growth factors is a multiple-step process: the role of the PH domain.

Authors:  A Bellacosa; T O Chan; N N Ahmed; K Datta; S Malstrom; D Stokoe; F McCormick; J Feng; P Tsichlis
Journal:  Oncogene       Date:  1998-07-23       Impact factor: 9.867

Review 2.  Deregulation of cell signaling in cancer.

Authors:  Filippo G Giancotti
Journal:  FEBS Lett       Date:  2014-02-20       Impact factor: 4.124

Review 3.  An update on the implications of cyclin D1 in oral carcinogenesis.

Authors:  P Ramos-García; J A Gil-Montoya; C Scully; A Ayén; L González-Ruiz; F J Navarro-Triviño; M A González-Moles
Journal:  Oral Dis       Date:  2017-03-31       Impact factor: 3.511

4.  Adenoid cystic carcinoma of the head and neck: Incidence and survival trends based on 1973-2007 Surveillance, Epidemiology, and End Results data.

Authors:  Christopher L Ellington; Michael Goodman; Scott A Kono; William Grist; Trad Wadsworth; Amy Y Chen; Taofeek Owonikoko; Suresh Ramalingam; Dong M Shin; Fadlo R Khuri; Jonathan J Beitler; Nabil F Saba
Journal:  Cancer       Date:  2012-01-31       Impact factor: 6.860

Review 5.  The significance of the Wnt pathway in the pathology of human cancers.

Authors:  Rooshdiya Karim; Gary Tse; Thomas Putti; Richard Scolyer; Soon Lee
Journal:  Pathology       Date:  2004-04       Impact factor: 5.306

Review 6.  PTEN: a new guardian of the genome.

Authors:  Y Yin; W H Shen
Journal:  Oncogene       Date:  2008-09-18       Impact factor: 9.867

7.  The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway.

Authors:  M Shtutman; J Zhurinsky; I Simcha; C Albanese; M D'Amico; R Pestell; A Ben-Ze'ev
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

Review 8.  The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment.

Authors:  Alexander Greenhough; Helena J M Smartt; Amy E Moore; Heather R Roberts; Ann C Williams; Christos Paraskeva; Abderrahmane Kaidi
Journal:  Carcinogenesis       Date:  2009-01-09       Impact factor: 4.944

9.  MDM2, P53, P21WAF1 and pAKT protein levels in genesis and behaviour of adenoid cystic carcinoma.

Authors:  Marina de Deus Moura de Lima; Yonara Maria Freire Soares Marques; Sérgio de Melo Alves; Vanessa Morais Freitas; Fernando Augusto Soares; Vera Cavalcanti de Araújo; Décio dos Santos Pinto; Andrea Mantesso
Journal:  Cancer Epidemiol       Date:  2009-06-06       Impact factor: 2.984

10.  Crosstalk Between MAPK/ERK and PI3K/AKT Signal Pathways During Brain Ischemia/Reperfusion.

Authors:  Jing Zhou; Ting Du; Baoman Li; Yan Rong; Alexei Verkhratsky; Liang Peng
Journal:  ASN Neuro       Date:  2015-10-06       Impact factor: 4.146

View more
  3 in total

Review 1.  Systemic therapies for salivary gland adenoid cystic carcinoma.

Authors:  Sosuke Sahara; Alexandra E Herzog; Jacques E Nör
Journal:  Am J Cancer Res       Date:  2021-09-15       Impact factor: 5.942

Review 2.  Role of Cyclooxygenase-2 in Head and Neck Tumorigenesis.

Authors:  Ellen Frejborg; Tuula Salo; Abdelhakim Salem
Journal:  Int J Mol Sci       Date:  2020-12-03       Impact factor: 5.923

3.  Quantitative ubiquitylomics reveals the ubiquitination regulation landscape in oral adenoid cystic carcinoma.

Authors:  Wen Li; Xiaobin Wang; Qian Zhang; Hanlin Wang; Wenxin Zuo; Hongliang Xie; Jianming Tang; Mengmeng Wang; Zhipeng Zeng; Wanxia Cai; Donge Tang; Yong Dai
Journal:  Biosci Rep       Date:  2021-08-27       Impact factor: 3.840

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.